Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-11
2009-12-01
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07625945
ABSTRACT:
This invention relates to a method of inhibiting the expression of TNFα or IL-1β with a compound of the following formula:wherein R1and R2are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
REFERENCES:
patent: 2002/0068098 (2002-06-01), Babish et al.
patent: 2004/0151792 (2004-08-01), Tripp et al.
Zhang et al., Phytother. Research, 13(2) (1999) pp. 157-159.
Achike et al., Clinical & Experimental Pharmacology & Physiology, 30 (2003), 605-615.
Mahadevan et al., Am. J. Gastroenterology, (Apr. 2002), 97(4): 910-4 (Abstract).
Mishra et al., Pharmacognosy Reviews, 1(2), (Jul.-Dec. 2007) 283-298.
Deng W.L. et al., Chinese Pharm. Bull. 17:195-198, 1982.
Habtemarian S., Andrographolide Inhibits the Tumor Necrosis factor-α-induced Upregulation of ICAM-1 Expression and Endothelial-monocyte Adhesion, Phytotherapy Research, 12:37-40, 1998.
Madav S. et al., Anti-inflammatory activity of andrographolide, Fitoterapia, 67:452-458, 1996.
Matsuda et al., Studies on the cell differentiation induces ofAndrographis paniculata, Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 33:433-440, 1991.
Rajagopal S. et al., Andrographolide, a potential cancer therapeutic agent isolated fromAndrographis paniculata, Journal of Experimental Therapeutics and Oncology 3:147-158, 2003.
Zhang C.Y. et al., Effects of 14-Deoxyandrographolide and 14-Deoxy-11, 12-Didehydroandrographolide on Nitric Oxide Production in Cultured Human Endothelial Cells, Phytotherapy Research, 13:157-159, 1999.
Wang, et al., “Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation”, Journal of Pharmacology and Experimental Therapeutics, 308(3):915-983, 2004, abstract.
Panossian, et al., “Effect of andrographolide and Kan Jang-fixed combination of extract SHA-10 and extract SHE-3-on proliferation of human lymphocytes, production of cytokines and immune activation markers in the whole blood cells culture”, Phytomedicine, 9(7):598-605, 2002, abstract.
Peng, et al., “Modulation of Lianbizi injection (andrographolide) on some immune functions”, Zhongguo Zhongyao Zazhi, 27(2):147-150, 2002, abstract.
See, et al., “Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers”, Immunological Investigations, 31(2):137-153, 2002, abstract.
Kumar, et al., “Anticancer and immunomodulatory potential of DRF-3188, an analogue of andrographolide”, Novel Compounds from Natural Products in the New Millennium, 205-216, 2004, abstract.
Habtemariam, S., “Natural Inhibitors of Tumor Necrosis Factor-α Production, Secretion and Function”Planta Med 66:303-313, 2000.
Xia, “Andrographolide Attenuates Inflammation by Inhibition of NF-kB Activation Through Covalent Modification of Reduced Cysteine 62 of p501” The Journal of Immunology, 4207-4217, 2004.
Cai Yu
Duan Jeff
Hong Jianrong
Ma Zhiming
Pan Ke
Hutchison MediPharma Enterprises Ltd.
Occhiuti Rohlicek & Tsao LLP
Spivack Phyllis G.
LandOfFree
Andrographolide and analogues as inhibitors of TNFα... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Andrographolide and analogues as inhibitors of TNFα..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Andrographolide and analogues as inhibitors of TNFα... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4085658